[Reflections on supervision strategies of new Tibetan drug registration].
Lists
Only you see this
Abstract
Tibetan medicine is an essential part of Chinese medicine and has unique theoretical experience and therapeutic advantages. According to the development principle of inheriting the essence, sticking to the truth, and keeping innovative, the supervision department should give clear and reasonable guidance considering the characteristics of Tibetan medicine, establish a standard system for quality control, clinical verification and evaluation, and accelerate the research and commercialization of new drugs. In view of the needs of drug supply-side reform and the current situation of Tibetan medicine and new pharmaceutical research, we ponder and provide suggestions on the confusion faced by the current supervision of Tibetan drug registration, hoping to contribute to the supervision strategy of Tibetan drug registration and the high-quality development of Tibetan medicine industry.
BibTeX
@inproceedings{liang2022reflections,
author = {Dan Liang and Tsring Pemba and Jiang-Yong Yu and Jianyuan Tang and Yuehua Zhou and Hua Hua and Tom Wei‐Wu Chen and Yanling Ai and Gang Zhou and Lei Zhang and Ting Wang and Yongwen Zhang and Chong Zou and Weixiong Liang and Jielai Xia and Naiqing Zhao and Xiaobo Sun and Wei Wei and Baohe Wang and Hong Ding and Guochen Wang and Tsring Puqiong and Phuntsok Kelsng and Guoqiang Wang},
title = {{[Reflections on supervision strategies of new Tibetan drug registration].}},
booktitle = {PubMed},
year = {2022},
doi = {10.19540/j.cnki.cjcmm.20220627.601},
}Loading related content...